Evidence map›Paper›PMID 35074928›Full record

ArticleLife science alliance2022

Nucleotide biosynthesis links glutathione metabolism to ferroptosis sensitivity.

Amy Tarangelo, Jason Rodencal, Joon Tae Kim, Leslie Magtanong, Jonathan Z Long, Scott J Dixon

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Metabolic Regulation of Ferroptosis in Breast Cancer.International journal of molecular sciences · 2025
    Review
  9. Genetic profile of ferroptosis in non-small cell lung carcinoma and pharmaceutical options for ferroptosis induction.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  10. Article
  11. Review
  12. Article
  13. Anticancer effects and mechanisms ofComputational and structural biotechnology journal · 2025
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. The cell biology of ferroptosis.Nature reviews. Molecular cell biology · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Amy TarangeloDepartment of Biology, Stanford University, Stanford, CA, USA.ORCID 0000-0002-0571-3582
Jason RodencalDepartment of Biology, Stanford University, Stanford, CA, USA.ORCID 0000-0001-5637-611X
Joon Tae KimDepartment of Pathology and Stanford, Chemistry, Engineering and Medicine for Human Health (ChEM-H), Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-6579-2278
Leslie MagtanongDepartment of Biology, Stanford University, Stanford, CA, USA.ORCID 0000-0002-0894-3156
Jonathan Z LongDepartment of Pathology and Stanford, Chemistry, Engineering and Medicine for Human Health (ChEM-H), Stanford University School of Medicine, Stanford, CA, USA.
Scott J DixonDepartment of Biology, Stanford University, Stanford, CA, USA sjdixon@stanford.edu.ORCID 0000-0001-6230-8199
Stanford University · US

Funding

Leveraging innovative technologies in basic and clinical cancer researchT32CA009302 · NCI · STANFORD UNIVERSITY · PI LAURA D ATTARDI, Aaron M Newman · 1985 to 2026
$19.1M
Characterizing the Regulation of FerroptosisR01GM122923 · NIGMS · STANFORD UNIVERSITY · PI Scott Dixon · 2017 to 2026
$3.4M
Investigating the Role of Metabolic Reprogramming in Cancer Cell Death SensitivityK00CA234650 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI TARANGELO, AMY · 2020 to 2022
$278k
Investigating the Role of Metabolic Reprogramming in Cancer Cell Death SensitivityF99CA234650 · NCI · STANFORD UNIVERSITY · PI TARANGELO, AMY · 2018 to 2019
$75k
NCI NIH HHS F99 CA234650NCI NIH HHS K00 CA234650NCI NIH HHS T32 CA009302NIGMS NIH HHS R01 GM122923
6 · The paper itself

Abstract

Nucleotide synthesis is a metabolically demanding process essential for DNA replication and other processes in the cell. Several anticancer drugs that inhibit nucleotide metabolism induce apoptosis. How inhibition of nucleotide metabolism impacts non-apoptotic cell death is less clear. Here, we report that inhibition of nucleotide metabolism by the p53 pathway is sufficient to suppress the non-apoptotic cell death process of ferroptosis. Mechanistically, stabilization of wild-type p53 and induction of the p53 target gene

Indexed as

ApoptosisCell Line, TumorCyclin-Dependent Kinase Inhibitor p21DNA DamageDNA ReplicationFerroptosisGlutathioneHumansNucleotidesTumor Suppressor Protein p53CDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21GlutathioneNucleotidesTumor Suppressor Protein p53

Identifiers

PMID35074928
PMCPMC8807879
OpenAlexW4225659885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.